Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on catalytic hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109970795A details a novel iridium catalyst achieving 98% ee. Discover cost reduction in chiral ligand manufacturing and supply chain advantages.
Patent CN104177253B details a novel route for 3-cyclopropylmethoxy-4-difluoromethoxybenzoic acid. Offers cost reduction and scalable supply for pharmaceutical partners.
Patent CN100480224C details a cost-effective Raney-Ni catalyzed route for Nabumetone, offering high purity and supply chain stability for global pharmaceutical manufacturers.
Patent CN118324597A introduces nanoporous copper-iron catalysis for high-yield nitro reduction. Discover cost-effective pharmaceutical intermediate manufacturing solutions.
Discover the novel preparation method for Metconazole intermediates via CN103664561A. Achieve higher purity and reduced toxicity for scalable agrochemical manufacturing.
Novel two-step synthesis of 2,6-diaminotoluene from 2-chloro-6-nitrotoluene. High purity, reduced waste, scalable industrial route for polyurethane and dye intermediates.
Patent CN107286043A details a low-pollution catalytic route for high-purity dye and pharma intermediates, offering significant cost reduction and supply chain reliability.
Patent CN102951980A reveals a novel iridium-catalyzed method for producing chiral amines, offering significant cost reduction in agrochemical intermediate manufacturing and scalable supply chain solutions.
Patent CN103145609A details a safe CTH method for 2,3-dichloropyridine. Eliminate high-pressure hydrogen risks and achieve scalable agrochemical intermediate manufacturing.
Patent CN1898229A reveals a high-yield route for tetrahydropyran-4-one. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN104844457B reveals a novel catalytic hydrogenation route for atorvastatin intermediates offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107954935A reveals a clean hydrogenation route for DMI. Discover cost reduction in fine chemical manufacturing and reliable specialty chemical supplier solutions.
Novel sulfonamide-based synthesis for high-purity quinolone intermediates. Safe, scalable process reducing hazardous reagents for reliable pharmaceutical supply chains.
Patent CN105504006B reveals a high-purity Neotame synthesis route offering substantial cost reduction and supply chain reliability for global food additive manufacturing.
Patent CN104557845A reveals a mild transfer hydrogenation route for Lubiprostone. Achieve high purity and cost reduction in API intermediate manufacturing with scalable methods.
Advanced preparation method for PARP inhibitor intermediates via salt formation. Enhances purity and yield for pharmaceutical manufacturing supply chains.
Patent CN112209967B reveals high-yield ligand synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN105669731B reveals a high-yield synthesis route for S1P regulatory intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN103025715A reveals a scalable route for Dabigatran intermediates using inorganic base hydrogenation, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN104402731A reveals metal salt-modified Raney Ni for efficient aniline synthesis. Offers cost reduction and supply chain reliability for fine chemical manufacturing.